Elucidating the specific pharmacological mechanism of action (MOA) of naturally developing compounds is often difficult. Whilst Tarselli et al. (60) designed the very first de novo artificial pathway to conolidine and showcased that this naturally developing compound properly suppresses responses to equally chemically induced and inflammation-derived pain, the pharmacologic https://augustnsuuu.blog5.net/87658721/conolidin-to-replace-traditional-painkillers-fundamentals-explained